Hochschulschrift
Integrative radiomics models for improved response assessment to neoadjuvant systemic treatment in breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
81 Blätter
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Ruprecht-Karls-Universität Heidelberg, Dissertation, 2024
- Classification
-
Medizin, Gesundheit
Informatik
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 1:32 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Time of origin
- 2023
Other Objects (12)
MRI-Based Radiomics Analysis for the Pretreatment Prediction of Pathologic Complete Tumor Response to Neoadjuvant Systemic Therapy in Breast Cancer Patients: A Multicenter Study
Neoadjuvant Treatment of Breast Cancer - Advances and Limitations
Is breast surgery necessary for breast carcinoma in complete remission following neoadjuvant chemotherapy?
Iodine map radiomics in breast cancer: prediction of metastatic status
Current and future role of neoadjuvant therapy for breast cancer
Value of F-18-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype
Neoadjuvant Radio(chemo)therapy for Breast Cancer: An Old Concept Revisited
AutoRadiomics: a framework for reproducible radiomics research
Effects of contrast-enhanced ultrasound treatment on neoadjuvant chemotherapy in breast cancer
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Axillary staging after neoadjuvant chemotherapy for initially node-positive breast carcinoma in germany
MRI-Based Radiomics Analysis for the Pretreatment Prediction of Pathologic Complete Tumor Response to Neoadjuvant Systemic Therapy in Breast Cancer Patients: A Multicenter Study
Neoadjuvant Treatment of Breast Cancer - Advances and Limitations
Is breast surgery necessary for breast carcinoma in complete remission following neoadjuvant chemotherapy?
Iodine map radiomics in breast cancer: prediction of metastatic status
Current and future role of neoadjuvant therapy for breast cancer
Value of F-18-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype
Neoadjuvant Radio(chemo)therapy for Breast Cancer: An Old Concept Revisited
AutoRadiomics: a framework for reproducible radiomics research
Effects of contrast-enhanced ultrasound treatment on neoadjuvant chemotherapy in breast cancer
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Axillary staging after neoadjuvant chemotherapy for initially node-positive breast carcinoma in germany
MRI-Based Radiomics Analysis for the Pretreatment Prediction of Pathologic Complete Tumor Response to Neoadjuvant Systemic Therapy in Breast Cancer Patients: A Multicenter Study
Neoadjuvant Treatment of Breast Cancer - Advances and Limitations
Is breast surgery necessary for breast carcinoma in complete remission following neoadjuvant chemotherapy?
Iodine map radiomics in breast cancer: prediction of metastatic status
Current and future role of neoadjuvant therapy for breast cancer
Value of F-18-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype
Neoadjuvant Radio(chemo)therapy for Breast Cancer: An Old Concept Revisited
AutoRadiomics: a framework for reproducible radiomics research
Effects of contrast-enhanced ultrasound treatment on neoadjuvant chemotherapy in breast cancer
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment